首页> 外文期刊>Journal of the American College of Surgeons >Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.
【24h】

Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.

机译:3型和4型肝门胆管癌的大手术:预后因素和长期预后。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Radical operation for hilar cholangiocarcinoma, including major hepatectomy with vascular resection, seems to improve longterm survival. This study retrospectively evaluates several prognostic risk factors that can influence survival after resection of types 3 to 4 Klatskin tumors. STUDY DESIGN: Between 1984 and 2003, 59 patients (36 men and 23 women) with types 3 to 4 hilar cholangiocarcinoma underwent liver resection with curative intent. Medical records and pathologic findings were reviewed to assess prognostic risk factors and survival. Disease-free and overall survival were analyzed using Kaplan-Meier and Cox proportional hazards models. RESULTS: Survival rates at 1, 3, and 5 years were 82%, 45%, and 20% respectively. In-hospital mortality was 5% and morbidity was 42%. In multivariable analysis, male gender (relative risk [RR] = 5.4; 95% CI, 2.2 to 13.5), absence of preoperative chemotherapy (RR = 4; 95% CI, 1.5 to 10.7), R1 biliary tract margin (RR = 2.6; 95% CI, 1.1 to 4.4), and metastatic celiac lymph nodes (RR = 19.9; 95% CI, 4 to 71.4) were found to be independent factors for overall survival. Pedicular metastatic lymph nodes were not associated with poorer overall survival. If biliary positive-margin is the only risk factor, the 5-year estimated overall survival is 70%. CONCLUSIONS: Major hepatectomy can improve outcomes of hilar cholangiocarcinoma. Compared with nonoperative treatment or R0 hepatectomy, R1 resection in patients with no other risk factor can offer longterm survival.
机译:背景:对肺门胆管癌进行根治性手术,包括进行大范围肝切除和血管切除术,似乎可以改善长期生存。这项研究回顾性评估了可能影响3至4型Klatskin肿瘤切除后生存的几种预后风险因素。研究设计:在1984年至2003年之间,对59例3至4型肝门胆管癌患者(36例男性和23例女性)进行了肝根治性切除。回顾病历和病理结果以评估预后危险因素和生存。使用Kaplan-Meier和Cox比例风险模型分析了无病生存期和总生存期。结果:1、3和5年生存率分别为82%,45%和20%。住院死亡率为5%,发病率为42%。在多变量分析中,男性(相对危险度[RR] = 5.4; 95%CI,2.2至13.5),未进行术前化疗(RR = 4; 95%CI,1.5至10.7),R1胆道切缘(RR = 2.6) ; 95%CI,从1.1到4.4)和转移性腹腔淋巴结转移(RR = 19.9; 95%CI,从4到71.4)是整体生存的独立因素。椎弓根转移性淋巴结转移与较差的总生存期无关。如果胆道正切缘是唯一的危险因素,则5年估计的总生存率为70%。结论:大肝切除术可改善肝门胆管癌的预后。与非手术治疗或R0肝切除术相比,无其他危险因素的患者进行R1切除可以提供长期生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号